Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects

Intravenous belimumab is approved for the treatment of systemic lupus erythematosus; subcutaneous self‐administration would enable greater patient access. This study assessed relative bioavailability, tolerability, and safety of 1 subcutaneous dose of self‐administered belimumab by healthy subjects...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Pharmacol Drug Dev
Main Authors: Struemper, Herbert, Murtaugh, Thomas, Gilbert, Jane, Barton, Matthew E., Fire, Joseph, Groark, James, Fox, Norma Lynn, Roth, David, Gordon, David
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5063175/
https://ncbi.nlm.nih.gov/pubmed/27163500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.219
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados